Abstracts

 

Assignments
Frequently Asked Questions
Step-by-Step Instructions
Rules and Guidelines
Topics and Keywords
Confirmations
Revisions
First Author Name Changes
Withdrawals
Acceptance and Programming
Publication
Licensing Agreement/Copyright Policy
How to Cite Abstracts
   

 

 

 

Abstract Submission Rules and Guidelines

Submission Deadline: June 2, 2011 (8:00 pm U.S. east coast time)

 

 

All authors will be asked to confirm the following statements when submitting an abstract: (1) I have read, understand and agree to the rules and guidelines; (2) I am submitting this abstract with the intent of attending the Congress and presenting; and (3) I confirm that each co-author has been informed of this abstract submission and has agreed to all information as it was submitted.

 

  1. Abstracts must be submitted with the intention that they will be presented if selected. First authors are expected to attend the meeting and make the presentation.  Authors should not submit abstracts if they do not plan to attend the meeting. Authors who do not present as scheduled and do not notify the Congress organizers in advance of the need to cancel may not be invited to present at future meetings. For platform/plenary presentations, substitution of the presenting individual is not allowed without prior written approval from the Program Committee Chairs.

     

  2. An individual may be first author (i.e., presenting author) of only one abstract. If an abstract includes co-authors, the presenting author’s name should be the first name to appear in the author listing. 

     

  3. There is no limit to the number of times an individual may appear as co-author on abstracts. The first author must inform and have agreement from all co-authors of the abstract submission. The first author will be required to confirm this information during the abstract submission process.

     

  4. With regard to research using human subjects, ICHG endorses the protections embodied in the Basic Principles of the Declaration of Helsinki and their expansion in the regulations governing research supported by the U.S. Government (45 CFR Part 46; 56 FR 28003). ICHG does not endorse and will not publish the results of research that was not conducted in accordance with these Principles. Investigations involving animals reported in abstracts must have been conducted in conformance with approved principles of the care and use of animals in research.

     

  5. With regard to research where a gene is identified, the first/presenting author must present the gene symbol and/or name or the identified marker at the meeting. Authors who do not conform to this policy at the meeting will be subject to sanctions as determined by the Scientific Program Committee.

     

  6. A complete abstract should include a statement of purpose, methods used, and a summary of results in sufficient detail to support the conclusion.  Statements such as "results will be described" should be avoided.

     

  7. All abstracts submitted will be considered for either a platform or poster presentation at the discretion of the Program Committee. When submitting your abstract, please check the appropriate box indicating whether you wish for your abstract to be considered for a plenary, platform or poster.

     

  8. Review of Abstracts.  All abstracts are reviewed by at least one Scientific Program Committee member and two ad hoc reviewers.  The reviewing process is strictly confidential. The Scientific Program Committee reviews all abstracts submitted for presentation and determines whether an abstract is suitable for platform or poster presentation.

     

  9. The Scientific Program Committee reserves the right to decline a presentation to any submitted abstracts that lack scientific content or merit, or merely announce the availability of a resource or service.

     

  10. Results or studies that have been published or that will be accepted for publication elsewhere prior to the submission deadline of June 2, 2011, may not be accepted for presentation.

     

  11. Abstract Licensing Agreement: In consideration of acceptance of the abstract by The American Society of Human Genetics (ASHG) and the International Congress of Human Genetics (ICHG), the submitting author grants ASHG/ICHG a nonexclusive, perpetual, worldwide license to copy, reproduce and publish the abstract in ASHG's/ICHG’s online or print publication of Congress abstracts and/or other compilations or collective works to be assembled and owned by ASHG/ICHG (together, "Collective Works") in any form or medium now existing or hereafter created throughout the world. The submitting author understands and agrees that ASHG/ICHG shall own all rights, including copyright, in and to the Collective Works including the right to: 

     

    1. Distribute, reproduce, license, display, perform, lend, lease, or transfer rights to the Collective Works to third parties,
    2. Prepare derivative works of the Collective Works, and
    3. Register the Collective Works in ASHG/ICHG’s own name with the U.S. Copyright Office. 

     

    It is understood that the submitting author and/or third parties with copyrights shall retain copyright in and to the abstract contributed by the submitting author to a Collective Work. The submitting author affirms that he/she is the author and owner of the abstract and holds all copyrights in and to the abstract, or has secured any third party permissions necessary to grant ASHG/ICHG the above rights. The submitting author is responsible for providing any related third party with a copy of this grant of rights.

     

  12. Publication of Abstracts: Abstracts selected for presentation and publication will be available at the Congress Website in August 2011.  At this time, your abstract and all information will become a matter of public record and may be referenced by ASHG, the Congress, media relations staff and others. Please review the abstract licensing agreement/copyright policy above.